Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hasselbalch, S. G.
Right arrow Articles by Paulson, O. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hasselbalch, S. G.
Right arrow Articles by Paulson, O. B.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 48, Issue 10 1915-1921, Copyright © 1999 by American Diabetes Association

ARTICLES

No effect of insulin on glucose blood-brain barrier transport and cerebral metabolism in humans

SG Hasselbalch, GM Knudsen, C Videbaek, LH Pinborg, JF Schmidt, S Holm and OB Paulson
Department of Neurology, University Hospital, Rigshospitalet, Copenhagen, Denmark. s.hasselbalch@dadlnet.dk

The effect of hyperinsulinemia on glucose blood-brain barrier (BBB) transport and cerebral metabolism (CMRglc) was studied using the intravenous double-indicator method and positron emission tomography using [18F]fluorodeoxyglucose as tracer (PET-FDG). Sixteen normal healthy control subjects (25 +/- 4 years old) were studied twice during a euglycemic and a euglycemic-hyperinsulinemic condition. Our hypothesis was that high physiologic levels of insulin did not affect the BBB transport or net metabolism of glucose. During insulin infusion, arterial plasma insulin levels increased from 48.5 to 499.4 pmol/l. The permeability-surface area products for glucose and FDG BBB transport obtained with the double-indicator method remained constant during hyperinsulinemia. Similarly using PET-FDG, no changes were observed in the unidirectional clearance of FDG from blood to brain. k2* (FDG transport from brain to blood) increased significantly by 15 and 18% (gray and white matter, respectively), and k4* (dephosphorylation of FDG) increased by 18%. The increase in k2* may be caused by insulin inducing a decrease in the available FDG brain pool. The increase in k4* may be related to an increased loss of labeled products during insulin fusion. Irrespective of these changes, CMRglc remained unchanged in all brain regions. We conclude that hyperinsulinemia within the normal physiologic range does not affect BBB glucose transport or net cerebral glucose metabolism.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 DiabetesHome page
S. Lerche, B. Brock, J. Rungby, H. E. Botker, N. Moller, A. Rodell, B. M. Bibby, J. J. Holst, O. Schmitz, and A. Gjedde
Glucagon-Like Peptide-1 Inhibits Blood-Brain Glucose Transfer in Humans
Diabetes, February 1, 2008; 57(2): 325 - 331.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
B. R. Landau, C. L. Spring-Robinson, R. F. Muzic Jr., N. Rachdaoui, D. Rubin, M. S. Berridge, W. C. Schumann, V. Chandramouli, T. S. Kern, and F. Ismail-Beigi
6-Fluoro-6-deoxy-D-glucose as a tracer of glucose transport
Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E237 - E245.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
K. Anthony, L. J. Reed, J. T. Dunn, E. Bingham, D. Hopkins, P. K. Marsden, and S. A. Amiel
Attenuation of Insulin-Evoked Responses in Brain Networks Controlling Appetite and Reward in Insulin Resistance: The Cerebral Basis for Impaired Control of Food Intake in Metabolic Syndrome?
Diabetes, November 1, 2006; 55(11): 2986 - 2992.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
O. Tschritter, H. Preissl, A. M. Hennige, M. Stumvoll, K. Porubska, R. Frost, H. Marx, B. Klosel, W. Lutzenberger, N. Birbaumer, et al.
The cerebrocortical response to hyperinsulinemia is reduced in overweight humans: A magnetoencephalographic study
PNAS, August 8, 2006; 103(32): 12103 - 12108.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
M. Hallschmid, B. Schultes, L. Marshall, M. Molle, W. Kern, J. Bredthauer, H. L. Fehm, and J. Born
Transcortical Direct Current Potential Shift Reflects Immediate Signaling of Systemic Insulin to the Human Brain
Diabetes, September 1, 2004; 53(9): 2202 - 2208.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
E. M. Bingham, D. Hopkins, D. Smith, A. Pernet, W. Hallett, L. Reed, P. K. Marsden, and S. A. Amiel
The Role of Insulin in Human Brain Glucose Metabolism: An 18Fluoro-Deoxyglucose Positron Emission Tomography Study
Diabetes, December 1, 2002; 51(12): 3384 - 3390.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
E. R. Seaquist, G. S. Damberg, I. Tkac, and R. Gruetter
The Effect of Insulin on In Vivo Cerebral Glucose Concentrations and Rates of Glucose Transport/Metabolism in Humans
Diabetes, October 1, 2001; 50(10): 2203 - 2209.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1999 by the American Diabetes Association.